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Abstract
Introduction: Osteoarthritis (OA) is associated with the metabolic syndrome, however the underlying mechanisms
remain unclear. We investigated whether low density lipoprotein (LDL) accumulation leads to increased LDL uptake
by synovial macrophages and affects synovial activation, cartilage destruction and enthesophyte/osteophyte
formation during experimental OA in mice.
Methods: LDL receptor deficient (LDLr−/−) mice and wild type (WT) controls received a cholesterol-rich or control diet for
120 days. Experimental OA was induced by intra-articular injection of collagenase twelve weeks after start of the diet. OA
knee joints and synovial wash-outs were analyzed for OA-related changes. Murine bone marrow derived macrophages
were stimulated with oxidized LDL (oxLDL), whereupon growth factor presence and gene expression were analyzed.
Results: A cholesterol-rich diet increased apolipoprotein B (ApoB) accumulation in synovial macrophages. Although
increased LDL levels did not enhance thickening of the synovial lining, S100A8 expression within macrophages
was increased in WT mice after receiving a cholesterol-rich diet, reflecting an elevated activation status. Both a
cholesterol-rich diet and LDLr deficiency had no effect on cartilage damage; in contrast, ectopic bone formation
was increased within joint ligaments (fold increase 6.7 and 6.1, respectively). Moreover, increased osteophyte size
was found at the margins of the tibial plateau (4.4 fold increase after a cholesterol-rich diet and 5.3 fold increase in
LDLr−/− mice). Synovial wash-outs of LDLr−/− mice and supernatants of macrophages stimulated with oxLDL led to
increased transforming growth factor-beta (TGF-β) signaling compared to controls.
Conclusions: LDL accumulation within synovial lining cells leads to increased activation of synovium and osteophyte
formation in experimental OA. OxLDL uptake by macrophages activates growth factors of the TGF-superfamily.
Introduction
Osteoarthritis (OA) is a common disease of unknown
etiology. The association of OA with metabolic syndrome
has long been established but the exact mechanism remains
unclear [1,2]. The idea that obesity enhances OA develop-
ment solely due to increased loading [3] is obsolete and
more often studies show the association between obesity
and OA development in non-weight-bearing joints [4-7].
Decreased levels of high-density lipoprotein (HDL) and
increased levels of low-density lipoprotein (LDL) particles
are, amongst other features, part of the metabolic syndrome
[8]. In a comparative analysis of serological parameters,
several studies demonstrated that OA patients have signifi-
cantly higher serum levels of LDL compared to healthy
controls [9,10]. Studies focusing on cardiovascular diseases,
such as atherosclerosis, show pro-inflammatory capacities
of LDL and modified LDL [11,12]. LDL particles form the
main transport vehicle of cholesterol from the liver to the
tissues. LDL can be oxidized in an inflammatory milieu
and, therefore, high levels of LDL result in enhanced
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oxidized LDL (oxLDL) levels in pathological conditions
where free radicals are present [13,14]. OxLDL is taken up
by macrophages via scavenger receptor class A, B (CD36)
and E (lectin-like oxLDL receptor-1; LOX-1), resulting in a
phenotype shift into a more inflammatory cell type [15-19].
A substantial population of OA patients develops a
thickened lining layer comprising macrophages that ex-
hibit an activated phenotype. Macrophages derived from
biopsies with early OA produce elevated amounts of
pro-inflammatory mediators [20]. Depletion of macrophages
from OA synovium using anti-CD14–conjugated magnetic
beads led to decreased levels of TNF-α, IL-1β, IL-6 and
IL-8 [21]. In previous studies we have shown that synovial
macrophages are crucial in the development of joint
pathology in experimental OA. Selective depletion of lining
macrophages using the clodronate-suicide technique prior
to induction of collagenase-induced OA strongly inhibited
development of cartilage destruction and osteophyte
formation, probably regulated by a strong decrease in me-
talloproteinase (MMP)-3 and −9 expression [22].
Transforming growth factor-β (TGF-β) and bone mor-
phogenetic proteins (BMP) are important growth factors
involved in the formation of new cartilage or bone in
ligaments (enthesophyte formation) or along the bone
surface (ectopic bone formation or osteophyte forma-
tion) [23]. In previous studies we showed that multiple
injections of members of the TGF-super family, such
as TGF-β or BMP-2, directly into the knee joint of the
mouse caused abundant enthesophyte/osteophyte forma-
tion [24,25]. Moreover, we postulated that local depletion
of synovial macrophages prior to injections of these growth
factors significantly inhibited new formation of cartil-
age/bone, suggesting that macrophage factors highly
contribute to this process [26,27].
The presence of high levels of LDL in OA joints with an
enhanced inflammatory environment may lead to uptake
of oxLDL by synovial lining macrophages, thereby con-
tributing to development of OA pathology. LDL receptor
deficient (LDLr−/−) mice, which are generally used in
atherosclerotic research [28], are unable to clear and
metabolize cholesterol-rich intermediate and low density
lipoproteins, causing hypercholesterolemia that can be
enhanced by a cholesterol-rich diet [29]. In this study, we
investigated the effect of increased serum LDL levels on
OA development in experimental collagenase-induced OA.
We focused on synovial thickening/activation, cartilage
damage and enthesophyte/osteophyte formation in both
LDLr−/− mice and mice receiving a cholesterol-rich diet.
Methods
Animals
Female mice homozygous for the Ldlrtm1Her mutation
(LDLr−/−) and their wild type (WT) control C57BL/6 J
were obtained from The Jackson Laboratory (Bar Harbor,
ME, USA). Mice were 10 to 13 weeks old when used in the
experiments, were housed in filter-top cages and received
food and water ad libitum. Animal studies were approved
by the Institutional Review Board (Animal Experiment
Committee Radboud University Medical Center) and were
performed according to the related codes of practice.
Collagenase-induced osteoarthritis
Mice were fed a standard diet or a cholesterol-rich diet
(+0.15% cholesterol; AB Diets, Woerden, the Netherlands).
Instability OA was induced by intra-articular injection of 1
unit bacterial collagenase (Sigma-Aldrich, St. Louis, MO,
USA) into the right knee on days 84 and 86 after start
of the diet [30]. On day 120, mice were weighed and
sacrificed, after which both left and right knee joints were
isolated and processed for histological analysis. Serum
samples were obtained to determine cholesterol levels.
Histological and immunohistochemical preparation
Isolated knee joints were fixed in 4% buffered formalin
and subsequently decalcified in formic acid and embed-
ded in paraffin. Eight representative sections (7 μm) of
each joint from various depths were stained with H & E
or Safranin O-fast green for histological analysis. For
immunohistochemistry, sections were deparaffinized and
endogenous peroxidase activity was blocked using 1%
H2O2 in methanol. Next, sections were incubated in
buffered citrate (pH 6.0) for antigen retrieval. Incubation
with 0.1% Triton X-100 was used for cell membrane
permeabilization, followed by incubation with rabbit
anti-mouse apolipoprotein B (ApoB; Abcam, Cambridge,
UK), rabbit anti-mouse S100A8 (kindly provided by Dr.
Vogl, Institute of Immunology, University of Muenster,
Germany), or normal rabbit immunoglobulin G (IgG) (R&D
Systems, Minneapolis, MN, USA) as control. Subsequently,
sections were incubated with the secondary antibody, bio-
tinylated goat anti-rabbit IgG, and binding was detected
using the ABC-HRP kit (Elite kit; Vector Laboratories,
Burlingame, CA, USA). Peroxidase was developed with
diaminobenzidine (DAB; Sigma-Aldrich) and sections were
counter-stained with hematoxylin. Sections were randomly
coded and scored in a blinded way by two independent
investigators.
Histological analysis
Synovial thickening and immunohistochemical staining
were measured using an arbitrary scoring system (0 to 3,
where 0 = no thickening/staining and 3 =most observed
thickening/staining). Three sections of various depths
were scored per knee joint.
Cartilage damage in the tibial-femoral joint was scored
using the OA score developed by Pritzker et al. [31],
adapted by us for mice (from 0 = no damage, to 30 =max-
imal damage) [32]. Five sections were scored per knee joint.
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Size of ectopic bone formation was measured by the
use of image analysis (Leica Qwin, Leica Microsystems,
Rijswijk, The Netherlands). Osteophytes and enthesophytes
were manually circled by an investigator blinded for the
experimental condition, after which the surface areas were
calculated by Leica-software. The mean cross-sectional sur-
face area in three sections per knee joint was determined,
including knee joints without ectopic bone formation.
Synovial wash-outs
Synovium was isolated from murine knee joints 7 and
36 days after collagenase injection. Tissue was weighed
and put in Roswell Park Memorial Institute medium
(RPMI; Gibco, Invitrogen, Carlsbad, CA, USA), enriched
with 48 μg/mL gentamicin (Centrafarm, Etten-Leur, The
Netherlands) and 0.1% BSA (Sigma-Aldrich) for one
hour at room temperature.
Bone marrow derived macrophages
Macrophages were differentiated out of bone marrow cells
using 15 ng/mL recombinant murine macrophage colony
stimulating factor (M-CSF; R&D Systems). For this, tibiae
from WT or LDLr−/− mice were removed and bone mar-
row cells were flushed with (D)MEM; Gibco) supplemented
with 10% FCS (Thermo Scientific, Waltham, MA, USA),
1 mM pyruvate (Gibco) and 48 μg/mL gentamicin.
Oxidized LDL preparation and macrophage stimulation
OxLDL was prepared from a large batch of LDL which was
first isolated by single-spin density-gradient ultracentrifuga-
tion from ethylenediaminetetraacetic acid (EDTA)-treated
blood donated by healthy volunteers and frozen in 10 mM
phosphate buffer (pH 7.4) containing 0.9% NaCl, 10% (w/v)
saccharose and 0.1 mM EDTA. LDL was thawed and
dialyzed for seven hours against saline in a Slide-A-Lyzer
cassette (Pierce Chemical Company, Rockford, IL, USA).
Subsequently, LDL was oxidized with 0.5 mg/mL copper
sulfate (Merck, Darmstadt, Germany) for 24 hours at
room temperature, after which oxLDL was dialyzed again
for one hour [33]. OxLDL concentration was determined
by the use of a bicinchoninic acid assay (Thermo Scientific)
and a Sunrise microplate reader (Tecan Group, Männedorf,
Switzerland). OxLDL was pre-incubated for 10 minutes
with 10 μg/mL polymixine B sulfate (Sigma-Aldrich) before
experimental use in order to rule out lipopolysaccharide
(LPS) interference. Macrophages were stimulated with
50 μg/mL oxLDL, or an equal volume of saline (also pre-
incubated with 10 μg/mL polymixine B sulfate) for 24 or
48 hours at 37°C. Stimulations were performed in 5% non
heat-inactivated FCS. Supernatant was used for functional
TGF-β and BMP analyses and cells were lysed in 500 μL
TRI-reagent (Sigma-Aldrich) for quantitative detection of
messenger RNA levels. All reactions were performed in
quadruple.
Quantitative real-time polymerase chain reaction
RNA was extracted using the single step RNA isolation
method described by Chomczynski and Sacchi [34].
Isopropanol (Merck) was used for precipitation, after which
the RNA pellet was washed twice with 75% ethanol.
The pellet was reconstituted in RNAse free water and
subsequently treated with DNase (Invitrogen). RNA was
reversed transcribed into complementary DNA (cDNA)
using reverse transcriptase, oligo(dT) primers and
dNTPs (Invitrogen).
Quantitative real-time PCR (qPCR) was performed using
StepOnePlus Real-Time PCR system and StepOne software
v2.2 (Applied Biosystems, Foster City, CA, USA), under
the following conditions: 10 minutes 95°C, followed by
40 cycles of 15 seconds 95°C and 1 minute 60°C. Data were
collected during the last 30 seconds of each cycle. Product
specificity was confirmed by assessment of dissociation-
characteristics. The reaction was performed in a total
volume of 10 μL, containing 3 μL diluted cDNA, 1 μL for-
ward primer (5 μM), 1 μL reverse primer (5 μM) and 5 μL
SYBR Green Master Mix (Applied Biosystems). The
following primers were designed with Primer Express
2.0 (Applied Biosystems) and manufactured by Biolegio
(Nijmegen, the Netherlands): GAPDH: 5′-GGCAAATTC
AACGGCACA-3′ (forward) and 5′-GTTAGTGGGGTC
TCGCTCCTG-3′ (reverse); IL-12p40: 5′-AGCTAACCAT
CTCCTGGTTTGC-3′ (forward) and 5′-CCACCTCTAC
AACATAAACGTCTTTC-3′ (reverse); TGF-β1: 5′-GCA
GTGGCTGAACCAAGGA-′3 (forward) and 5′-AAGAG
CAGTGAGCGCTGAATC-3′ (reverse); BMP2: 5′-CGCA
GCTTCCATCAC-3′ (forward) and 5′-GCCGGGCCGTT
TTCC-3′ (reverse); BMP4: 5′-CCGCTTCTGCAGGAAC
CA-3′ (forward) and 5′-AGTGCGTCGCTCCGAATG-3′
(reverse); BMP7: 5′-ACGGACAGGGCTTCTCCT-3′ (for-
ward) and 5′-ATGGTGGTATCGAGGGTG-3′ (reverse).
Relative expression levels were presented as ΔΔCt, being
the threshold cycle (Ct) value corrected for GAPDH and
unstimulated control.
CAGA-Luc and BRE-Luc reporter constructs
3T3 cells (ATCC, Manassas, VA, USA) were transduced
with a CAGA-Luciferase reporter plasmid (CAGA-Luc) or
a BMP responsive-luciferace reporter plasmid (BRE-Luc)
for two and a half hours with a multiplicity of infection of
10. Both plasmids were kindly provided by Dr. Ten Dijke
(Department of Molecular Cell Biology, Leiden University
Medical Center, the Netherlands). After 24 hours, the
transduction efficiency of CAGA-Luc was checked with
fluorescence microscopy, confirming the presence of GFP
that is constitutively active in this construct. The transduced
cells were then stimulated overnight with macrophage
supernatant or synovial wash-outs under serum-free
conditions, after which luminescence was measured.
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Statistical analysis
Statistical differences between two values were calculated
using a student’s t-test or Mann Whitney U test depending
on Gaussian distribution. Statistical differences between
more than two values were tested using a one-way analysis
of variance (ANOVA) or Kruskal-Wallis test, followed by a
Bonferoni or Dunns post test, respectively. All analyses
were performed using Graph Pad Prism 5 (GraphPad
Software, La Jolla, CA, USA) and P-values less than 0.05
were considered to be significant. Data are depicted as
mean ± standard error of the mean (SEM).
Results
A cholesterol-rich diet increased serum cholesterol levels
and enhanced ApoB uptake by LDLr deficient synovial
lining cells
To investigate the effects of enhanced serum cholesterol
levels during pathogenesis of experimental collagenase-
induced OA, both WT and LDLr−/− mice were fed a
standard diet or cholesterol-rich diet for 120 days. A
cholesterol-rich diet resulted in a 21% increase of body
weight in WT mice (from 23.8 g ± 0.4 to 28.8 g ± 1.5;
P = 0.05), but, in contrast, did not significantly affect the
weight of LDLr−/− mice (Figure 1A). Serum analysis for
cholesterol levels showed that a cholesterol-rich diet
in WT mice increased serum LDL concentration by
128% (from 0.54 mmol/L ± 0.04 to 1.23 mmol/L ± 0.13;
P = 0.006). In LDLr deficient mice, enhanced serum LDL
concentration following a cholesterol-rich diet was even
more pronounced (428% raise, from 7.33 mmol/L ± 0.46
to 38.73 mmol/L ± 3.11; P<0.0001; Figure 1B). Apart from
enhanced serum LDL levels, local effects of a cholesterol-
rich diet and LDLr deficiency were also investigated.
Expression of ApoB, which is the main protein in oxLDL
particles, was examined by immunohistochemistry. Both
a cholesterol-rich diet and LDLr deficiency enhanced
uptake of ApoB by the synovium. Particularly, cells in the
lining layer accumulated ApoB within their cytoplasm.
Mice deficient for the LDLr showed a significant increase
in ApoB staining after receiving a cholesterol-rich diet,
suggesting enhanced up-take of oxLDL (Figure 1C). These
results suggest a positive relation between oxLDL accu-
mulation by lining macrophages and serum LDL levels.
High serum cholesterol levels did not alter synovial
thickening but increased the activation status of the
macrophage particularly in wild type mice during
collagenase-induced osteoarthritis
Since high serum levels of LDL resulted in enhanced
uptake of (modified) LDL by the synovial lining layer cells,
we further investigated whether enhanced serum LDL
levels during collagenase-induced experimental OA affected
synovial thickening. Histology of knee joints at day 36
after induction of experimental OA showed moderate
synovial thickening in WT mice on a normal diet (1.4 ±
0.2; Figure 2A). Synovial thickness, however, was not sig-
nificantly higher in mice that received a cholesterol-rich
diet, nor was it significantly higher in mice deficient for
the LDL receptor. To study the contribution of the macro-
phage to lining layer activation, immunostaining with
S100A8 was performed. S100A8 is expressed only by acti-
vated macrophages but not by fibroblasts [35]. WT mice
showed an increased S100A8 expression after receiving
a cholesterol-rich diet (from 0.43 ± 0.16 to 1.13 ± 0.35;
P = 0.035). In LDLr−/− mice increased S100A8 expression
after a cholesterol-rich diet did not reach significance
Figure 2B).
High serum cholesterol levels caused by a
cholesterol-rich diet did not alter cartilage
destruction in collagenase-induced osteoarthritis
Since we show that a cholesterol-rich diet is capable of
activating macrophages, we further investigated whether
high serum cholesterol levels affect cartilage damage.
Overall cartilage destruction was mild (mean score WT
mice without cholesterol-rich diet 6.1 ± 1.5; Figure 3).
Although WT mice that received a cholesterol-rich diet
showed marginal differences in cartilage damage compared
to mice receiving a normal diet at the lateral side of the
femur and both lateral and medial side of the tibia, these
values did not reach significance. In line with this, no dif-
ferences in cartilage damage were seen in LDLr deficient
mice between the group receiving the normal diet and the
group receiving the cholesterol-rich diet. Moreover, no
differences between cartilage damage in WT mice on the
normal diet and LDLr deficient mice on the normal diet
were observed (Figure 3).
Increased serum cholesterol levels result in enhanced
bone formation in ligaments during experimental
osteoarthritis
Earlier studies have shown that synovial macrophages
are crucial in mediating new formation cartilage/bone in
ligaments and along the bone surface. Since formation
of enthesophytes are a consistent and early feature of OA
[36], leading to ligament rigidity and less functionality of
the joint, we first examined the effects of high cholesterol
levels on ectopic bone formation in collateral and cruciate
ligaments. While only four out of ten WT mice with OA
on a normal diet showed enthesophyte formation, there
were eight out of ten WT mice on a cholesterol-rich diet
that presented enthesophyte formation. In LDLr deficient
mice on a normal diet, eight out of ten mice showed
enthesophyte formation, whereas there were nine out of
ten mice in the LDLr deficient group on a cholesterol-rich
diet that showed this condition (Figure 4A). Both a
cholesterol-rich diet and LDLr deficiency resulted in a
significantly increased size of enthesophytes (fold increase
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of 6.7 and 6.1, respectively; P<0.05). In contrast, the com-
bination of LDLr−/− and a cholesterol-rich diet only showed
a trend towards an increased total size of enthesophytes
compared to WT mice on a normal diet; however, values
did not reach significance (Figure 4B and C).
High serum cholesterol levels result in increased
osteophyte formation and presence of active TGF-β in
collagenase-induced osteoarthritis
Since enthesophyte formation in joint ligaments strongly cor-
relates with osteophyte formation [23], we next investigated
whether serum cholesterol levels affected osteophyte
formation. We measured osteophyte size at the margins of
the lateral and medial side of the tibial plateau and femoral
condyles using image analysis. LDLr deficient mice, receiv-
ing a cholesterol-rich diet, showed significant enhancement
of osteophyte formation at the lateral side of the tibial plat-
eau, when compared to WT mice with a cholesterol-rich
diet (fold increase 2.7; P<0.01). Even more pronounced was
the increase in osteophyte formation in LDLr deficient
mice on a normal diet, compared to WT mice on the same
diet (fold increase 5.3; P<0.001; Figure 5A and B). Besides
A
C
B
Figure 1 A cholesterol-rich diet leads to increased serum LDL levels and ApoB accumulation in synovial lining. Both WT and LDLr
deficient mice received a normal or cholesterol-rich diet for 120 days. Increased body weight following a cholesterol-rich diet was observed in
WT mice but not in LDLr deficient mice (A). Serum LDL levels were increased both in WT and LDLr deficient animals after receiving a cholesterol-rich
diet (B). Synovial lining cells (predominantly macrophages) of LDLr deficient mice showed increased intracellular ApoB accumulation, suggesting
increased oxLDL uptake (C). *P<0.05; ***P<0.001 versus WT mice with normal diet; ‡P<0.001 versus LDLr deficient mice with normal diet and WT mice
with cholesterol-rich diet. n = 10 mice per group. ApoB, apolipoprotein B; LDL, low density lipoprotein; LDLr, low density lipoprotein receptor; oxLDL,
oxidized low density lipoprotein; WT, wild type.
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AB
Figure 2 Cholesterol-rich conditions lead to an activated synovium, rather than synovial thickening. Thickening of the synovial lining
layer was determined in hematoxylin and eosine stained sections, using an arbitrary score between 0 and 3. All mice showed moderate synovial
thickening with no significant differences between various groups (A). Immunohistochemistry, however, showed an increase in S100A8
expression in WT mice after receiving a cholesterol rich diet, suggesting enhanced macrophage activation (B). *P<0.05. n = 10 mice per group.
WT, wild type.
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increased osteophyte formation due to LDLr deficiency,
a cholesterol-rich diet further increased osteophyte forma-
tion at the lateral site of the tibial plateau in LDLr deficient
mice (fold increase 1.8; P<0.05). At the medial side of
the tibia, a cholesterol-rich diet resulted in increased
osteophyte formation in WT mice (fold increase 4.4;
P<0.01). Thus, both a cholesterol-rich diet and LDLr
deficiency cause increased osteophyte formation at the
margins of the tibial plateau. At the margins of the femoral
condyles, no significant differences in osteophyte formation
were found between the various groups (data not shown).
In previous studies we have shown that TGF-β and BMPs
are major growth factors involved in driving new formation
of cartilage/bone [24,25]. We therefore tested synovial
wash-outs of WT and LDLr−/− mice for the presence of
active TGF-β using a CAGA-Luc assay (Figure 5C). Both
on the 7th and 36th day after collagenase injection, levels
of activated TGF-β were significantly higher in LDLr−/−
mice on a cholesterol-rich diet, compared to WT mice on
a cholesterol-rich diet.
OxLDL stimulated macrophages activate TGF-β in vitro
As ApoB accumulation in synovial macrophages correlated
with increased ectopic bone formation in both WT and
LDLr−/− mice, we investigated whether oxLDL stimulated
macrophages are capable of producing anabolic factors that
may be responsible for this process. For that reason, bone
marrow derived macrophages were cultured with oxLDL
for 24 hours. Staining with oil red O indeed showed a high
uptake of oxLDL by macrophages, which did not alter cell
viability (Figure 6A). Analysis of RNA expression did not
show upregulation of important growth factors known
to be involved in ectopic bone formation such as TGF-β,
BMP2, -4 and −7, while IL12p40, a positive control for
murine oxLDL-laden macrophages [37], did show a signifi-
cant down regulation with a ΔΔCt of 2.0 ± 0.13 (Figure 6B).
Next, we studied the presence of active TGF-β and BMP
using specific bioassays. When supernatant of macrophages
that were stimulated with oxLDL for 48 hours was func-
tionally tested for TGF-β activity using the CAGA-Luc
assay, we found a significant 2.9 fold increase in signal
A
B
Figure 3 Increased serum cholesterol levels do not affect cartilage damage during experimental OA. Cartilage damage was scored at the
medial and lateral side of the tibial plateau and femoral condyles (A). No significant differences were found between the different groups. B shows
representative pictures (stained with safranin O - fast green) of the medial femoral condyle and tibial plateau of four OA joints. Two representative
pictures of naïve joints show that the observed cartilage damage was due to collagenase injection rather than age or genomic and environmental
factors. ns = not significant. n = 10 mice per group. OA, osteoarthritis.
de Munter et al. Arthritis Research & Therapy 2013, 15:R178 Page 7 of 13
http://arthritis-research.com/content/15/6/R178
(P<0.05), while oxLDL alone did not increase TGF-β
activity (Figure 6C). The BRE-Luc assay, which measures
active BMP, did also show an increase in signal by super-
natant of oxLDL-laden macrophages, albeit to a lesser
extent (fold increase 1.8; P<0.05; Figure 6D).
Discussion
In the present study, we show that enhanced serum LDL
cholesterol levels increase ectopic bone formation in mice
with collagenase-induced OA. By using both a cholesterol-
rich diet and LDLr deficiency, we demonstrated that an
enhanced LDL cholesterol level in particular, rather than
LDLr deficiency or a specific food element, is responsible
for the enhancement of ectopic bone formation.
From previous studies we know that synovial lining cells
are important for OA pathology. Selective elimination
of synovial macrophages from the intimal lining of the
knee joint prior to induction of collagenase-induced OA
A
B
C
Figure 4 Enhanced serum cholesterol levels increase ectopic bone formation in ligaments. The size of cartilage and bone formations was
measured using digital image analysis. The incidence of ectopic bone formation was increased after a cholesterol-rich diet, LDL receptor deficiency
and the combination of these two (A). The photographs depict representative examples of ectopic bone formation at the medial collateral ligament
(B). When cross-sectional surface areas were measured, a cholesterol-rich diet or LDL receptor deficiency showed increased total enthesophyte size in
ligaments (C). ns = not significant compared to other groups; ‡P<0.05 compared to WT mice with normal diet. LDL, low density lipoprotein; WT,
wild type.
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ameliorated the development of both cartilage damage
and ectopic bone formation. In mice that lack the LDLr,
a cholesterol-rich diet led to a strong increase in ApoB
staining within the lining layer. Every LDL particle contains
a single ApoB molecule that can be used as a marker for
LDL and oxLDL uptake [38]. The accumulation of ApoB
in synovial lining cells of LDLr deficient mice suggests that
lining cells in an OA joint take up oxLDL in a cholesterol-
rich environment. Macrophages can phagocytize LDL via
the LDLr which is suppressed when LDL serum levels rise,
leading to regulation of LDL uptake into the cell [39].
Under inflammatory conditions, LDL is oxidized and
phagocytized by scavenger type A and B receptors lacking
this negative feedback loop [40]. A macrophage is a very
A
B
C
Figure 5 Increased serum cholesterol levels enhance osteophyte formation at the margins of the tibial plateau and increase active
TGF-β presence. Osteophyte size was digitally measured at the margins of the tibial plateau (A). B shows representative photos (stained with
safranin O - fast green) of osteophytes at the lateral side of the tibial plateau. The presence of active TGF-β was found to be increased in LDLr−/−
mice on a cholesterol-rich diet compared to WT mice on a cholesterol-rich diet by testing synovial wash-outs on a CAGA-LUC assay (C). *P<0.05;
**P<0.01; ***P<0.001. n = 10 mice per group. LDLr, low density lipoprotein receptor; WT, wild type.
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plastic cell type which can differentiate into activated M1
or suppressive M2 subtypes. Recently we found in in vitro
studies that M2 macrophages express higher levels of
SR-A and CD36 receptors compared to M1 macrophages
and that enhanced uptake of oxLDL by M2 macrophages
changed the suppressive character of this cell type into an
M1-like macrophage releasing enhanced levels of IL-1 and
IL-6 [16]. Although uptake of oxLDL in the lining layer
of the LDLr−/− mice receiving a cholesterol-rich diet
was strongly enhanced, no elevation of S100A8 staining
was observed. S100A8 is a member of the alarmin family
which is particularly produced by activated macrophages
but not by non-activated macrophages and has been
described as a marker for macrophage activation [35].
The lack of S100A8 staining in LDLr−/− mice suggests that
uptake of large amounts of oxLDL by lining macrophages
does not enhance the production of pro-inflammatory
molecules and chemokines and, therefore, does not alter
synovial thickening and cartilage destruction. In contrast,
high cholesterol levels in WT mice induced only minor
uptake of oxLDL by lining macrophages, but strongly
enhanced S100A8 levels. This accumulation of S100A8
within the lining layer might explain the trend of in-
creased cartilage destruction observed in WT mice on
a cholesterol-rich diet. S100A8 production by synovial
macrophages may be driven by moderate uptake of oxLDL
or LDL, while excessive uptake of oxLDL may inhibit
production of pro-inflammatory factors by synovial mac-
rophages. Another explanation of the slight increase in
cartilage damage observed in WT mice on a cholesterol-
rich diet (Figure 3) is that it might also be due to the
increased body weight (Figure 1A). Nevertheless, by using
a cholesterol-rich diet rather than a high-fat diet, we
minimized weight gain, preventing amelioration of the OA
process via increased loading [41]. Lack of cartilage damage
in cholesterol-rich conditions may also be explained by the
A
C D
B
Figure 6 LDL- and oxLDL-laden macrophages enhance anabolic processes by activating TGF-β and to a lesser extent BMP, rather than
increase production of TGF-β or BMP. Bone marrow derived cells were differentiated into macrophages, after which they were stimulated with
50 mg/mL oxLDL or an equal volume of PBS. Staining the cells with oil red O showed uptake of oxLDL (A). RNA expression did not show significant
upregulation of TGF-β, BMP2, BMP4 or BMP7 (B); however, a functional TGF-β reporter gene luciferase (CAGA-Luc) assay did show increased presence
of active TGF-β (C). Furthermore, the BMP responsive luciferase (BRE-Luc) assay also showed increased activity in supernatant of oxLDL stimulated
macrophages, albeit to a lesser extent (D). UD = undetectable; *P<0.05 versus unstimulated control; **P<0.01; ns = no significant regulation. BMP,
bone morphogenetic protein; LDL, low density lipoprotein; oxLDL, oxidized low density lipoprotein.
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increased presence of active TGF-β which protects the
cartilage from proteoglycan depletion and matrix break-
down, as described in an earlier study by Van Beuningen
et al. [42]. From our own experience, we know that the
experimental model which is used here is less severe in
female mice compared to males. Although all mice in
this experiment developed cartilage lesions, the OA
scores were relatively low. It would be interesting to repeat
our experiment in a more severe model, investigating
whether increased cholesterol-associated cartilage damage
is detected.
Apart from cartilage destruction, new formation of
cartilage and bone is also observed in ligaments and loca-
tions along the bone surface during collagenase-induced
OA. Focusing on ligaments (enthesophyte formation), we
noticed that an increase in LDL levels by a cholesterol-rich
diet markedly enhanced new cartilage and bone formation.
OxLDL might directly induce proliferation and differ-
entiation of stem cells present within the ligaments, or
indirectly by enhancing growth factor production in
synovium. Several studies have shown that oxLDL has a
toxic effect on proliferation and differentiation of stem
cells, and, in line with that, our own findings show that
oxLDL (50 μg/mL) is highly toxic for stem cells (data
not shown), whereas similar concentrations do not affect
macrophage viability (Figure 6A) [43-47]. For that reason,
we assume that enthesophyte formation may be more
related to the effects of oxLDL on synovial lining activity.
In previous studies in our lab it was found that intra-
articular injection of the growth factors TGF-β and BMP2
resulted in formation of osteophytes [24,25]. Moreover, in
the absence of synovial macrophages, injection of TGF-β
was less able to induce new formation of cartilage and
bone, suggesting that macrophages are crucial in mediating
TGF-β effects [26]. Furthermore, we found that spheroid
formation in a mesenchymal cell line was increased when
these cells were co-cultured with macrophages, whereas
total TGF-β levels in supernatant did not increase [27].
This fits with the present study where we show that there
is increased activation of TGF-β, rather than production
after stimulation of macrophages with oxLDL. Using
supernatants of oxLDL stimulated macrophages, strongly
elevated levels of active TGF-β and, to a lesser extent,
BMP were measured. Also in vivo, LDLr−/− mice show
an increased presence of TGF-β compared to WT mice,
suggesting that this in vitro observation could very well
reflect the in vivo mechanism. TGF-β was measured
using a CAGA-Luc assay in which the CAGA promoter
is coupled to a luciferase gene which becomes activated by
active TGF-β via TGF-β receptor 1. TGF-β is released in
an inactive form and can be activated by enzymes such as
MMP2 and MMP9 [48]. These enzymes may be released
either by activated synovial macrophages or by synovial
fibroblasts in response to pro-inflammatory factors released
by the macrophage. Recently, Ishikawa et al. demonstrated
that apart from macrophages in rheumatoid arthritis
fibroblast-like synoviocytes can also accumulate oxLDL
via LOX-1, resulting in massive MMP production [49].
Studies are now in progress to define the factors involved
in TGF-β activation. In addition to TGF-β activation,
increased BMP activation was found after stimulation
of macrophages with oxLDL. Enhanced BMP presence
can also contribute to the observed bone formation, since
previous studies showed that TGF-β is important for initi-
ating osteophyte formation, whereas BMP are mainly
involved at later stages in the process of endochondral
ossification [50]. Also osteoarthritic chondrocytes have
been shown to express LOX-1 and could, therefore, be
affected by oxLDL directly [51]. Although our data support
that (ox)LDL affects chondrocytes indirectly via synovial
activation, it would be interesting to investigate how hyper-
cholesterolemia could influence the chondrocytes directly
and how this affects OA development.
We did not find osteophyte or enthesophyte formation in
naïve knee joints of mice with an LDLr deficiency receiving
a cholesterol-rich diet (data not shown). This would suggest
that systemically enhanced LDL levels alone are not
sufficient to induce joint pathology. Only when there are
pro-inflammatory or damage associated stimuli present
(that is, during OA or instability), may enhanced LDL levels
result in increased osteophyte/enthesophyte formation.
Conclusions
This study shows for the first time that increased LDL
cholesterol levels in an OA milieu are able to enhance
ectopic bone formation. Our experimental data points
towards a potential mechanism in which uptake of oxLDL
by synovial lining macrophages results in activation of
TGF-β and to a lesser extent BMP. Further research is
needed in order to elucidate what factors in particular are
responsible for the enhanced levels of active TGF-β and
BMP, since direct production does not seem to increase
according to mRNA expression levels. Nevertheless, this
mechanism provides a firm step forward to unraveling
possible factors affecting etiopathology of OA and osteo-
phyte formation in particular.
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